CSPC & Growth

CSPC & Growth (Beijing) Investment Management is a venture capital and strategic investment firm associated with the CSPC Pharmaceutical Group, one of China's leading pharmaceutical companies. The firm focuses on investing in innovative life science and biotechnology companies, particularly those developing novel therapeutic platforms and drug candidates. It frequently participates in financing rounds for clinical-stage biotechs, such as its recent investment in Degron Therapeutics' Series A extension. By leveraging the industrial resources and expertise of the CSPC Group, the firm aims to foster growth in the healthcare sector and identify strategic opportunities for its parent organization. Its portfolio includes companies working on advanced modalities like molecular glue degraders and targeted protein degradation.